(Q68435139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

multicenter clinical trial

1 reference

inferred from title

essential hypertension

1 reference

M Searle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

R Dathan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

S Dean

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

C C Christensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

A Westheim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

299-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00315116

24 September 2019

exact match

0 references

cites work

The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology

1 reference

12 December 2020

Doxazosin in patients with hypertension

1 reference

12 December 2020

Lipoproteins, cardiovascular disease, and death. The Framingham study

1 reference

12 December 2020

The effects of antihypertensive agents on serum lipids and lipoproteins

1 reference

12 December 2020

Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in Man

1 reference

12 December 2020

Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00315116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147909%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference